Eric Poma
Chief Executive Officer bei MOLECULAR TEMPLATES, INC.
Vermögen: 41 456 $ am 31.03.2024
Profil
Eric E.
Poma is the founder of Molecular Templates, Inc. (founded in 2000) where he holds the title of Director, Chief Executive & Scientific Officer.
He is currently the Chief Executive Officer & Director at Molecular Templates OpCo, Inc. Dr. Poma's former positions include Vice President-Business Development at ImClone LLC (2001-2013) and Secretary & Vice President-Business Development at Innovive Pharmaceuticals, Inc. (2009-2013).
Dr. Poma's education history includes an undergraduate and doctorate degree from The University of North Carolina at Charlotte and an MBA from The Leonard N Stern School of Business.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
23.01.2024 | 18 507 ( 0,34% ) | 41 456 $ | 31.03.2024 |
Aktive Positionen von Eric Poma
Unternehmen | Position | Beginn |
---|---|---|
MOLECULAR TEMPLATES, INC. | Chief Executive Officer | 01.01.2000 |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Chief Executive Officer | - |
Ehemalige bekannte Positionen von Eric Poma
Unternehmen | Position | Ende |
---|---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | - |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Corporate Officer/Principal | - |
Ausbildung von Eric Poma
The University of North Carolina at Charlotte | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MOLECULAR TEMPLATES, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
ImClone LLC
ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is developing compounds for the treatment of cancer. It currently have four products in development; INNO-406, tamibarotene, INNO-206 and INNO-406. The Group operates in the United States of America. | Health Technology |
Molecular Templates OpCo, Inc.
Molecular Templates OpCo, Inc. Financial ConglomeratesFinance Molecular Templates OpCo, Inc. provides medical services. The company is headquartered in Austin, TX. | Finance |